Literature DB >> 9434633

Transcriptional repression by the promyelocytic leukemia protein, PML.

S Vallian1, J A Gäken, I D Trayner, E B Gingold, T Kouzarides, K S Chang, F Farzaneh.   

Abstract

Acute promyelocytic leukemia is characterized by the presence of a t(15; 17) chromosomal translocation which results in the expression of a chimeric gene product, PMLRAR alpha, consisting of an N-terminal-truncated retinoic acid receptor-alpha fused to a C-terminal-truncated PML. Several structural features, and regions of homology to known transcription factors, suggest that PML may be involved in the regulation of gene expression. In this study we have analyzed the transcriptional regulatory activity of PML using chimeric GAL4/PML constructs and GAL4-responsive reporter plasmids. The data presented demonstrate that PML, when fused to the DNA-binding domain of GAL4 (GAL4/PML), inhibits transcription from GAL4-responsive promoters. The magnitude of this repression is cell type and promoter dependent, and deletion studies show that the putative coiled-coil and part of the serine-rich regions of PML are required for this activity. These regions are also shown to be responsible for the repression of transcription activity from the EGFR promoter. The data presented also demonstrate that GAL4/PML can recruit PMLRAR alpha resulting in the retinoid-inducible transcriptional activation of a GAL4-responsive promoter, a function dependent on the presence of the coiled-coil region of PMLRAR alpha.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9434633     DOI: 10.1006/excr.1997.3801

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PML-retinoic acid receptor alpha oncoprotein.

Authors:  S Tsuzuki; M Towatari; H Saito; T Enver
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  No evidence for PML-RARa bcr1 fusion gene in colorectal cancer.

Authors:  Marta Herreros-Villanueva
Journal:  Mol Biol Rep       Date:  2011-12-14       Impact factor: 2.316

3.  Repression of PML nuclear body-associated transcription by oxidative stress-activated Bach2.

Authors:  Satoshi Tashiro; Akihiko Muto; Keiji Tanimoto; Haruka Tsuchiya; Hiroshi Suzuki; Hideto Hoshino; Minoru Yoshida; Joachim Walter; Kazuhiko Igarashi
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

4.  Transcriptional regulation is affected by subnuclear targeting of reporter plasmids to PML nuclear bodies.

Authors:  Gregory J Block; Christopher H Eskiw; Graham Dellaire; David P Bazett-Jones
Journal:  Mol Cell Biol       Date:  2006-09-11       Impact factor: 4.272

5.  The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases.

Authors:  W S Wu; S Vallian; E Seto; W M Yang; D Edmondson; S Roth; K S Chang
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

6.  Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.

Authors:  Y Xu; J H Ahn; M Cheng; C M apRhys; C J Chiou; J Zong; M J Matunis; G S Hayward
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies.

Authors:  Akio Iwanami; Beatrice Gini; Ciro Zanca; Tomoo Matsutani; Alvaro Assuncao; Ali Nael; Julie Dang; Huijun Yang; Shaojun Zhu; Jun Kohyama; Issay Kitabayashi; Webster K Cavenee; Timothy F Cloughesy; Frank B Furnari; Masaya Nakamura; Yoshiaki Toyama; Hideyuki Okano; Paul S Mischel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

Review 8.  Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies.

Authors:  Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  PML colocalizes with and stabilizes the DNA damage response protein TopBP1.

Authors:  Zhi-Xiang Xu; Anna Timanova-Atanasova; Rui-Xun Zhao; Kun-Sang Chang
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

10.  The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter.

Authors:  S Vallian; K V Chin; K S Chang
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.